Correlation Between Genscript Biotech and Zentalis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Genscript Biotech and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genscript Biotech and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genscript Biotech and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on Genscript Biotech and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genscript Biotech with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genscript Biotech and Zentalis Pharmaceuticals.
Diversification Opportunities for Genscript Biotech and Zentalis Pharmaceuticals
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Genscript and Zentalis is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Genscript Biotech and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and Genscript Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genscript Biotech are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of Genscript Biotech i.e., Genscript Biotech and Zentalis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Genscript Biotech and Zentalis Pharmaceuticals
Assuming the 90 days horizon Genscript Biotech is expected to generate 0.55 times more return on investment than Zentalis Pharmaceuticals. However, Genscript Biotech is 1.83 times less risky than Zentalis Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Zentalis Pharmaceuticals Llc is currently generating about -0.03 per unit of risk. If you would invest 140.00 in Genscript Biotech on October 26, 2024 and sell it today you would lose (4.00) from holding Genscript Biotech or give up 2.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.16% |
| Values | Daily Returns |
Genscript Biotech vs. Zentalis Pharmaceuticals Llc
Performance |
| Timeline |
| Genscript Biotech |
| Zentalis Pharmaceuticals |
Genscript Biotech and Zentalis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Genscript Biotech and Zentalis Pharmaceuticals
The main advantage of trading using opposite Genscript Biotech and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genscript Biotech position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.| Genscript Biotech vs. Telix Pharmaceuticals Limited | Genscript Biotech vs. Keros Therapeutics | Genscript Biotech vs. Zentalis Pharmaceuticals Llc | Genscript Biotech vs. Innovent Biologics |
| Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |